首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1372609

全球疝網裝置市場 - 2023-2030

Global Hernia Mesh Devices Market - 2023-2030

出版日期: 2023年10月18日 | 出版商:

DataM Intelligence | 英文 190 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

全球疝網裝置市場將於 2022 年達到 100 萬美元，預計到 2030 年將達到 100 萬美元，在 2023-2030 年預測期內年複合成長率為 100%。

透過手術將疝氣網放置在腫塊區域附近，以修復薄弱的肌肉和疝氣。它是一種薄的多孔編織材料，由生物合成材料製成，可為手術過程中受損的組織提供強度和結構。

腹股溝疝氣是腹股溝區域最常見的疝氣類型，醫療保健專業人員在此放置和修復網片。 10% 至 15% 的男性和 2% 的女性一生中會發生腹股溝疝氣。

市場動態：促進因素與限制因素

疝氣修補手術的發生率增加

當內臟從腹部肌肉壁的薄弱區域突出時，就會發生疝氣。這會導致胃部皮膚下（通常靠近皮膚）出現異常隆起。疝氣網裝置被放置在腹股溝或海軍區域，以便修復器官的腫塊和肌肉上的壓力。全世界範圍內疝氣和疝氣修復手術的盛行率正在增加。

例如，根據美國食品藥物管理局的數據，到 2023 年，美國每年估計進行 100 萬例腹股溝疝氣修補手術。這些手術估計每年近 2000 萬例，使疝氣修復手術成為全球最常進行的普通外科手術之一。

根據美國兒科學會的數據，2023 年，每 1,000 名活產嬰兒中，腹股溝疝氣的發生率接近 8 至 50 例，在出生體重不足的嬰兒中，這一比例增至約 20%。

此外，根據《國際醫學科學期刊》2023 年的數據，美洲的盛行率為 4.36%，歐洲為 4.06%，東南亞為 4.88%。男性報告的腹股溝疝氣終生盛行率 (20-27%) 遠高於女性 (3-6%)。

使用網片進行手術後疝氣復發

許多患者在疝氣修補後會出現復發性腹股溝疝氣。即使採用最好的手術技術和措施，由於補片放置不當、補片吸收等多種原因，補片後仍會出現疝氣復發。縫合修復後復發率為8.2%，補片修復後復發率為2.7 %。復發率也取決於所使用的網格材料。根據貝勒醫學院 2023 年的研究表明，高達 30% 的疝氣修復手術會導致復發。

有關此報告的更多詳細資訊 - 索取樣品

Hernia occurs when the internal organs protrude through a weak area in the muscular wall of the abdomen. This gives rise to an abnormal bulge under the stomach's skin, usually near the skin. Hernia mesh devices are placed at the groin or naval area so that the organs' lumps and stress on the muscle are repaired. The prevalence of hernia and hernia repair surgeries is increasing worldwide.

For instance, according to the Us Food and Drug Administration, 2023, an estimated 1 million inguinal hernia repairs are performed yearly in the US. These surgeries are estimated at nearly 20 million a year, making hernia repair surgeries one of the most commonly performed general surgery procedures worldwide.

According to the American Academy of Pediatrics, 2023, the incidence of inguinal hernias is nearly 8 to 50 per 1000 live births, increasing to approximately 20% in deficient birth weight infants.

Furthermore, according to the International Journal of Medical Sciences, 2023, the prevalence is 4.36% in the Americas, 4.06% in Europe, and 4.88% in Southeast Asia. Men reported a much higher lifetime prevalence of inguinal hernias (20-27%) than women (3-6%).

Hernia recurrences with surgeries using mesh

Recurrent inguinal hernia is observed in many patients after the hernia is repaired. Even after the best surgical technique and measures, hernia recurrence is seen after placing a mesh due to many reasons like improper mesh placement, mesh absorption, etc. The recurrence rates were 8.2 percent after suture repair and 2.7 percent after mesh repair. The recurrence also depends upon the mesh material used. According to Baylor College of Medicine, 2023, studies have shown that up to 30% of hernia repairs can result in a recurrence.

For more details on this report - Request for Sample

Segment Analysis

The global hernia mesh devices are segmented based on hernia type, product type, mesh size, end user and region.

The Synthetic mesh segment accounted for approximately 43.3% of the market share

The synthetic mesh is expected to hold the largest segment due to its wide application in hernia repair surgeries. Synthetic meshes are either permanent, as in the case of nonabsorbable, or temporary, as absorbable. It is made up of materials like polyester, polypropylene, etc.

These are the most common types of materials used in hernia surgeries. Product launch with advancements brings more efficacy to the procedure performed on the patient suffering from a hernia.

For instance, in April 2022, Ariste Medical, LLC, a pre-commercial drug & device company, received FDA approval for its drug-embedded, synthetic hernia mesh in the United States to reduce microbial infections during surgical implantation.

In February 2022, Futura Surgicare Pvt. Ltd., an Indian-based medical device manufacturer, has recently introduced a range of surgical meshes under its brand Dolphin Mesh. These tension-free dual surgical meshes can be used for laparoscopic tension-free hernia repairs.

Geographical Analysis

North America accounted for approximately 40.2% of the market share in 2022

North America is expected to hold the largest market share due to the rising prevalence of hernia cases and surgeries among the U.S. population. For instance, according to the Cleveland Clinic Organisation, hiatal hernias affect around 20% of people in the U.S. and 50% over 50.

For instance, according to Springer Nature Journal, in the United States alone, 500,000 and 750,000 patients are operated on for inguinal hernias annually.

Additionally, around 90% of hernia surgeries annually in the U.S. use hernia mesh. Usually, there are no causes or symptoms of hernia. A lump can be seen protruding from the stomach area, abdomen area, and groin area.

COVID-19 Impact Analysis:

COVID-19 impacted the hernia mesh devices market due to the worldwide disruption in the supply chain. There is a shift in the focus of the research and development towards COVID-19 vaccines and drugs. As lockdowns were implemented worldwide, the diagnostic procedures were postponed to later stages; hence, the surgeries were halted during COVID-19 unless they were essential. This has impacted the hernia meshes as the devices are not used for treatment. The number of hospital visits has drastically decreased during the period, and hence, most of the diagnostic centers did not prioritize hernia repairs.

Competitive Landscape

The major global players in the hernia mesh devices market include: Medtronic plc, C. R. Bard Inc., Ethicon Inc., Atrium Medical Technologies, W. L. Gore & Associates, Inc., B. Braun Melsungen AG, LifeCell Corporation, Baxter International, Inc, Cook Medical Incorporated, Herniamesh S.r.l among others.

Key Developments

In June 2023, Advanced Medical Solutions Group plc received US Food and Drug Administration approval for the use of LiquiBandFix8 to to fix mesh to tissue inside the body during inguinal hernia surgery. It has also been approved for closing the peritoneum, a membrane that surrounds the abdominal cavity.
In May 2023, Tissium, a tissue reconstruction company, secured $53.8m to launch its tissue repair platform and to commercialize other products that are in the pipeline, nerve repair, hernia repair, and cardiovascular sealants.

Why Purchase the Report?

To visualize the global hernia mesh devices market segmentation based on hernia type, product type, mesh size, end user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of hernia mesh devices market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global hernia mesh devices market report would provide approximately 69 tables, 68 figures, and 190 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Hernia Type
3.2. Snippet by Product Type
3.3. Snippet by Mesh Size
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Driver
  - 4.1.1.1. Increasing incidence of hernia repair surgeries
  - 4.1.1.2.
- 4.1.2. Restraints
  - 4.1.2.1. Hernia recurrences with surgeries using mesh
  - 4.1.2.2.
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Hernia Disease Statistics
5.5. Regulatory Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Hernia Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hernia Type
- 7.1.2. Market Attractiveness Index, By Hernia Type
7.2. Inguinal Hernia*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Incisional Hernia
7.4. Umbilical Hernia
7.5. Femoral Hernia
7.6. Hiatal Hernia
7.7. Others

8. By Product Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.1.2. Market Attractiveness Index, By Product Type
8.2. Synthetic Mesh*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  - 8.2.2.1. Absorbable
  - 8.2.2.2. Non-absorbable
  - 8.2.2.3. Hybrid
8.3. Animal-derived Mesh
8.4. Others

9. By Mesh Size

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mesh Size
- 9.1.2. Market Attractiveness Index, By Mesh Size
9.2. 15 cm x 9 cm*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. 15 cm x 10 cm

10. By End User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals and Clinics*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Specialty Centers
10.4. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hernia Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mesh Size
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hernia Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mesh Size
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. UK
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Spain
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hernia Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mesh Size
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hernia Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mesh Size
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hernia Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mesh Size
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Medtronic plc
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. C. R. Bard Inc
13.3. Ethicon Inc
13.4. Atrium Medical Technologies
13.5. W. L. Gore & Associates, Inc
13.6. B. Braun Melsungen AG
13.7. LifeCell Corporation
13.8. Baxter International, Inc
13.9. Cook Medical Incorporated
13.10. Herniamesh S.r.l